This is a non-core endpoint: only basic statistics are computed.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
21
Check minimum number of events None
21
Include endpoints None
21
Remove individuals based on genotype QC
21
HYDROXY_DEPOT
Control definitions
Control exclude
RHEUMA_CHRYSTAL
Extra metadata
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
M11
Name in latin
Morbus hydroxyapatitum deponens
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Hydroxyapatite deposition disease
based on the number of shared cases.
Broader endpoints:
- Other crystal arthropathies
- Crystal arthropathies, rheuma endpoint
- Polyarthropathies
- Finngen Rheumatological endpoints
- Arthropathies
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 21 | 15 | 6 |
| Unadjusted prevalence (%) | 0.01 | 0.01 | 0.00 |
| Mean age at first event (years) | 59.63 | 59.82 | 59.15 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: HYDROXY_DEPOT – Hydroxyapatite deposition disease
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Hydroxyapatite deposition disease
↥Endpoint not on priority list, no data to show.